Deutsche Bank
ETON icon

Deutsche Bank’s Eton Pharmaceutcials ETON Stock Holding History

Deutsche Bank’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$960K Buy
26,522
+5,386
+25% +$158K ﹤0.01% 2400
2026
Q1 		$522K Buy
21,136
+2,887
+16% +$50.5K ﹤0.01% 2551
2025
Q4 		$309K Buy
18,249
+850
+5% +$15K ﹤0.01% 2816
2025
Q3 		$378K Hold
17,399
– – ﹤0.01% 2696
2025
Q2 		$248K Buy
+17,399
New +$275K ﹤0.01% 2848
2021
Q2 		– Sell
-11,872
Closed -$87K – 4653
2021
Q1 		$87K Sell
11,872
-1,222
-9% -$10.4K ﹤0.01% 4054
2020
Q4 		$106K Buy
13,094
+4,479
+52% +$34.6K ﹤0.01% 3816
2020
Q3 		$68K Buy
8,615
+1,829
+27% +$12.5K ﹤0.01% 3728
2020
Q2 		$37K Buy
+6,786
New +$33.7K ﹤0.01% 3933
2019
Q2 		– Sell
-1,621
Closed -$12K – 5339
2019
Q1 		$12K Buy
1,621
+1,321
+440% +$9.18K ﹤0.01% 4879
2018
Q4 		$1K Buy
+300
New +$1.84K ﹤0.01% 5096

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Deutsche Bank's ETON Position: Q2 2026 in Review

Deutsche Bank increased its Eton Pharmaceutcials (ETON) stake by 25% in Q2 2026, buying an estimated $158K and bringing the position to 26,522 shares worth $960K. The position accounts for ﹤0.01% of the portfolio, ranked #2400.

Deutsche Bank first reported a position in ETON in Q4 2018 and has held it in 11 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Deutsche Bank held 26,522 shares of Eton Pharmaceutcials worth $960K as of Q2 2026.
  • Deutsche Bank bought 5,386 Eton Pharmaceutcials shares in Q2 2026, an estimated $158K.
  • Eton Pharmaceutcials made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2400 holding.
  • Deutsche Bank first reported a position in Eton Pharmaceutcials in Q4 2018 and has held it in 11 quarters since.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.